Tajuk
Quizartinib For Treatment Of Patients With Relapsed/Refractory Fms-Like Tyrosine Kinase 3 (FLT3)-Internal Tandem Duplication (ITD) Acute Myeloid Leukaemia (AML)
Tahun
2019-003-S
Lampiran-lampiran
2019-003-S QUIZARTINIB FOR TREATMENT OF PATIENTS WITH RELAPSEDREFRACTORY FMS-LIKE TYROSINE KINASE 3 (FLT3)-INTERNAL TANDEM DUPLICATION (ITD) ACUTE MYELOID LEUKAEMIA (AML).pdf